Abstract |
Macrophage Stimulating Protein (MSP) is the only known ligand for the receptor tyrosine kinase Ron. The MSP/Ron pathway is involved in several important biological processes, including macrophage activity, wound healing, and epithelial cell behavior. A role for MSP/Ron in breast cancer has recently been elucidated, wherein this pathway regulates tumor growth, angiogenesis, and metastasis. Here, we review the recent literature surrounding MSP/Ron function in tumor cells, inflammatory cells, and osteoclasts - cell types that often coexist in breast tumor microenvironments. We discuss the potential implications of MSP/Ron activity occurring concurrently in these cell types on tumor progression and metastasis. Lastly, we outline the potential for targeting MSP/Ron as a novel therapy for breast cancer, and for other cancer types.
|
Authors | Kelsi L Kretschmann, Henok Eyob, Saundra S Buys, Alana L Welm |
Journal | Current drug targets
(Curr Drug Targets)
Vol. 11
Issue 9
Pg. 1157-68
(Sep 2010)
ISSN: 1873-5592 [Electronic] United Arab Emirates |
PMID | 20545605
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review)
|
Chemical References |
- Proto-Oncogene Proteins
- macrophage stimulating protein
- Hepatocyte Growth Factor
- RON protein
- Receptor Protein-Tyrosine Kinases
|
Topics |
- Animals
- Breast Neoplasms
(drug therapy, metabolism, physiopathology)
- Cell Line, Tumor
- Disease Progression
- Epithelial Cells
(metabolism)
- Female
- Hepatocyte Growth Factor
(metabolism)
- Humans
- Inflammation
(physiopathology)
- Macrophages
(physiology)
- Mice
- Mice, Transgenic
- Molecular Targeted Therapy
- Neoplasms
(drug therapy, metabolism)
- Osteoclasts
(metabolism)
- Proto-Oncogene Proteins
(metabolism)
- Receptor Protein-Tyrosine Kinases
(antagonists & inhibitors, metabolism)
- Signal Transduction
- Wound Healing
|